You are here

Resize Text
See all clinical trials

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest (Zephyr)

This is an open label study in which eligible IPF subjects who are using supplemental oxygen at rest will receive GBT440 orally daily.

Clinical Trial Information

Protocol
IRB# 24027, WIRB# 20162203
Phase
2
Conditions
Idiopathic Pulmonary Fibrosis
Investigator
Gerard J Criner, MD
Coordinator
Sylvia Johnson, RN

Visit clinicaltrials.gov for full clinical trial description.

Contact

For more information about this trial or to inquire about eligibility, email breathe@temple.edu

Full Title

A Phase II Open Label Study to Evaluate the Effect of GBT440 on Hypoxemia in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Who Are Using Supplemental Oxygen at Rest (ZEPHYR)